Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B.
Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B. Lung Cancer. 2001 Feb-Mar; 31(2-3):311-7.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Deoxycytidine
Disease Progression
Female
Humans
Infusions, Intravenous
Male
Mesothelioma
Middle Aged
Treatment Outcome
authors with profiles
Hedy Kindler